Genital Herpes: The hidden epidemic?;Herpès génital: L'épidémie silencieuse?

Medecine et Hygiene

Volumn 59, Issue 2341, 2001, Pages 781-789

  Jolivet, P ^a   Sahli, R ^a   Meylan, P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; PENCICLOVIR; VALACICLOVIR;

CASE FINDING; DISEASE CONTROL; DISEASE TRANSMISSION; EPIDEMIC; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; MASS SCREENING; PRESCRIPTION; RECURRENT DISEASE; REVIEW; SEROLOGY; SEROPREVALENCE; SEXUAL TRANSMISSION; UNITED STATES; VERTICAL TRANSMISSION; VIRUS EXCRETION;

EID: 0035804705     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world
2. Herpes simplex viruses
3. Herpes simplex viruses and their replication
4. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for Herpes simplex virus type-specific antibodies
5. Testing for type-specific antibody to Herpes simplex virus-implications for clinical practice
6. Recurrence rates in genital herpes after symptomatic first-episode infection
7. Recurrences after oral and genital Herpes simplex virus infection. Influence of site of infection and viral type
8. The characteristic site-specific reactivation phenotypes of VHS-1 and HSV-2 depend upon the latency-associated transcript region
9. The quantity of latent viral DNA correlates with the relative rates at which Herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks
10. Herpes simplex virus type 2 in the United States, 1976 to 1994
11. The burden of infection with HSV-1 and HSV-2 in England and Wales: Implications for the changing epidemiology of genital herpes
12. Decline of Herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern
13. Changes in prevalence of Herpes simplex virus type 1 and 2 antibodies from 1973 to 1993 in the rural districts of Japan
14. A prospective study of new infections with Herpes simplex virus type 1 and type 2
15. First episodes of genital herpes in a Swedish STD population: A study of epidemiology and transmission by the use of Herpes simplex virus (HSV) typing and specific serology
16. Changing trends in genital Herpes simplex virus infection in Bergen, Norway
17. Risk factors for the sexual transmission of genital herpes
18. The acquisition of Herpes simplex virus during pregnancy
19. Neonatal Herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor
20. Herpes simplex virus type 1 and 2 in Switzerland
21. Théorie et pratique de l'échantillonage: L'exemple de l'enquête MONICA
22. Genital Herpes simplex virus infections: Clinical manifestations, course, and complications
23. Primary and recurrent Herpes simplex virus type 2-induced meningitis
24. Herpes simplex virus type 2 meningitis in the absence of genital lesions: Improved recognition with use of the polymerase chain reaction
25. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis
26. Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis
27. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time
28. Herpes simplex virus: The importance of asymptomatic shedding
29. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes
30. Development of clinically recognizable genital lesions among women previously identified as having «asymptomatic» Herpes simplex virus type 2 infection
31. Frequent genital Herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment
32. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons
33. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: Frequency, patterns, and risk factors
34. Frequency of symptomatic and asymptomatic Herpes simplex virus type 2 reactivations among human immunedeficiency virus-infected men
35. Increased genital shedding of Herpes simplex virus type 2 in HIV- seropositive women
36. Penciclovir cream for the treatment of Herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial
37. Treatment of first episodes of genital Herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects
38. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis
39. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial
40. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes
41. Valaciclovir for the suppression of recurrent genital Herpes simplex virus infection: A large-scale dose range-finding study
42. Oral famciclovir for the suppression of recurrent genital herpes: A randomized controlled trial
43. Famciclovir for the suppression of symptomatic and asymptomatic Herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial
44. Recurrence and resistance patterns of Herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir
45. Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient Herpes simplex virus
46. New therapies and prevention strategies for genital herpes